Upgrade to SI Premium - Free Trial

Scholar Rock (SRRK) PT Raised to $33 at Wedbush, After Company Releases Clinical Trial Data

October 27, 2020 12:30 PM
Wedbush analyst David Nierengarten raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles